Dosage and administration
Adults: When practical, cleanse theaffected area with mild soap andwarm water, and rinse thoroughlyGently dry by patting or blotting withtoilet tissue or a soft cloth beforeapplication of this product.
Ophyte Tattoo Numbing Cream
- Manufacturer
- Changsha Beiliang E-commerce Co., Ltd
- Effective date
- 2023-12-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:05:35
Label at a glance#
ProductOphyte Tattoo Numbing Cream
Active ingredientLIDOCAINE
Label structure13 sections
Storage and handling
Keep away from direct sunlight orheat. Store at room temperaturebetween 15°C and 30°C(59°F-86°F). This package is child-resistant.Keep out of reach of children. In case of accidental overdose oringestion, call a doctor or poisoncontrol center immediately. Do not use this product if the sealis broken or missing.
Label contents#
Full prescribing information#
Active Ingredient
Lidocaine 5%
Purpose
Local Anesthetic
Use
For temporary relief of local and anorectal itching, discomfort, and inflammation associated with anorectal disorders.
For temporary relief of pain, burning, and soreness.
Warnings
lf symptoms worsen or do notimprove within 7 days, seek medicaadvice.
Do not exceed the recommendeodaily dosage without doctor's
instruction.
Consult a doctor immediately if bleeding occurs.
Do not insert this product into the rectum using fingers or any applicator.
Some people may be allergic to the ingredients.Discontinue use and consult a doctor if symptoms persist or worsen,including redness,
irritation, swelling, or pain.
Note: Discontinue use and consult a
doctor if symptoms persist or
worsen, including redness, irritation.
swelling, or pain due to possible
allergies to product ingredients
Do not use
Some people may be allergic tothe ingredients. Discontinue use andconsult a doctor if symptoms persistor worsen,including rednessirritation,swelling,or pain.
When Using
If symptoms worsen or do not improve within 7 days, seek medicaladvice.Do not exceed the recommended daily dosage without doctor'sinstruction.Consult a doctor immediately if bleeding occurs.
Do not insert this product into the rectum using fingers or any applicator.
Some people may be allergic to the ingredients. Discontinue use and consult a doctor if symptoms persistor worsen,including redness,irritation,swelling,or pain.
Stop Use
Discontinue use and consult adoctor if symptoms persist orworsen, including redness, irritation,swelling, or pain due to possibleallergies to product ingredients.
Ask Doctor
Discontinue use and consult a doctor if symptoms persist or worsen, including redness, irritation. swelling, or pain due to possible
allergies to product ingredients
Keep Oot Of Reach Of Children
This package is child-resistant.Keep out of reach of children
Directions
Adults: When practical, cleanse theaffected area with mild soap andwarm water, and rinse thoroughlyGently dry by patting or blotting withtoilet tissue or a soft cloth beforeapplication of this product.
Other information
Keep away from direct sunlight orheat.
Store at room temperaturebetween 15°C and 30°C(59°F-86°F).
This package is child-resistant.Keep out of reach of children. In case of accidental overdose oringestion, call a doctor or poisoncontrol center immediately. Do not use this product if the sealis broken or missing.
Inactive ingredients
Vitamin E Allantoin, Mineral Oil.Dimethicone,MethylparabenPropylparaben, Petrolatum, IPBCDiazolidinyl Urea, Glycerin,Cetostearyl Alcohol, IsopropylMyristate, Propylene Glycol,Ammonium,Methacrylate, PurifiedWater, Laurocapram, Steareth-2.Steareth-21 Rose Oil
PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 83887-002-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-a391-d83d-e063-dadaa90ab31f | 83887-002 |
| 83887-002-02 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-a391-d83d-e063-dadaa90ab31f | 83887-002 |
| 83887-002-03 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-a391-d83d-e063-dadaa90ab31f | 83887-002 |
| 83887-002-04 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-a391-d83d-e063-dadaa90ab31f | 83887-002 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83887-002-01 | Ophyte Tattoo Numbing Cream | 30 g in 1 TUBE | CREAM | 30 | 1 | |
| 83887-002-02 | Ophyte Tattoo Numbing Cream | 50 g in 1 BOTTLE | CREAM | 50 | 1 | |
| 83887-002-03 | Ophyte Tattoo Numbing Cream | 60 g in 1 BOTTLE | CREAM | 60 | 1 | |
| 83887-002-04 | Ophyte Tattoo Numbing Cream | 100 g in 1 BOTTLE | CREAM | 100 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Ophyte Tattoo Numbing Cream
- Numbing Cream
- PROPYLENE GLYCOL
- IODOPROPYNYL BUTYLCARBAMATE
- DIAZOLIDINYL UREA
- ALLANTOIN
- GLYCERIN
- ROSE OIL
- DIMETHICONE
- ISOPROPYL MYRISTATE
- METHYLPARABEN
- AMMONIUM METHACRYLATE
- STEARETH-2
- LIDOCAINE
- MINERAL OIL
- PROPYLPARABEN
- PETROLATUM
- CETOSTEARYL ALCOHOL
- LAUROCAPRAM
- .ALPHA.-TOCOPHEROL
- WATER
- STEARETH-21
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 83887-002 | 83887-002-01, 83887-002-02, 83887-002-03, 83887-002-04 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0d281d68-021f-675d-e063-6294a90a07dd | 0d281d68-021e-675d-e063-6294a90a07dd | 2023-12-23 | Warnings | 0d281d68-021f-675d-e063-6294a90a07dd 0d281d68-021e-675d-e063-6294a90a07dd |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.